Increased levels of CK-18 fragments using this noninvasive parameter for evaluating apoptosis have already been described in patients with acute and chronic liver diseases [38,50-53], graft-versus-host disease [54], infectious gastroenteritis [52], and carcinoma [28]. Here, KRT18 is linked to carcinoma.